AI Healthcare Solutions for Precision and Speed in Drug Discovery

Our AI-powered solutions are transforming drug discovery by automating critical stages, reducing time to market, and improving accuracy to help pharmaceutical companies stay competitive.

OUR CLIENTS

Pharma Leaders Trust Our AI-Accelerated Drug Discovery Solutions

We collaborate with leading pharmaceutical companies to accelerate drug discovery, leveraging AI-driven solutions that streamline workflows and enhance testing precision for faster and more accurate results.

Our Clients
Gold Gym Sonangol Buzztime Hyundai Rusam Gold Gym Sonangol Buzztime Hyundai Rusam Gold Gym Sonangol Buzztime Hyundai Rusam Gold Gym Sonangol Buzztime Hyundai Rusam
CASE STUDY

Proven Success Stories in AI-Accelerated Drug Discovery

AI-Powered Accelerated Drug Discovery

We partnered with a leading pharmaceutical company, and through our tailored retail AI solutions, we helped them overcome delays and high costs in drug discovery. By utilizing predictive analytics and automated molecular screening, we analyzed large datasets to identify promising drug candidates rapidly. This streamlined process reduced human error, improved testing accuracy, and accelerated development, ultimately lowering costs and speeding up time-to-market.

  • 40% reduction in drug discovery timelines
  • 50% improvement in compound screening accuracy
  • 25% reduction in development costs
Explore more
View more Projects
USECASES

See How AI Accelerates Drug Discovery

Discover how AI accelerates drug discovery, optimizing every stage from screening to analytics with real-world use cases.

Target Identification and Validation

Our AI models analyze vast scientific datasets and literature using advanced techniques like graph neural networks (GNNs) and natural language processing (NLP) to identify actionable biological targets with high precision.

De Novo Molecular Design

Using generative AI and LLMs, we design new chemical entities or biological molecules tailored to specific pharmacological profiles, accelerating the creation of innovative drug candidates.

Lead Optimization with AI

Intellivon’s AI-driven lead optimization enhances the identification of promising compounds, accelerating drug development while ensuring efficiency and precision at every stage.

AI-based ADMET Property Prediction

Our AI models predict ADMET properties early in the drug discovery process, helping you assess compound viability and streamline development timelines.

AI for Predictive Toxicology

Using predictive toxicology, we analyze compound safety profiles, reducing risk and speeding up decision-making to deliver safer drugs faster.

Virtual Screening and Compound Prioritization

Intellivon’s AI-driven virtual screening helps prioritize the most promising compounds, optimizing your pipeline and accelerating the journey from discovery to delivery.

Biomarker Discovery

We accelerate biomarker discovery through AI, helping identify critical targets faster and improving the efficiency of drug development and personalized therapies.

WHY CHOOSE US

The Trusted Choice for Next-Generation Drug Discovery

Global pharma leaders trust our AI solutions for faster, more accurate drug discovery, with customized results that reduce costs and accelerate time-to-market.

Automation of Key Stages

Our AI solution automates critical stages, such as molecular screening and predictive analytics, streamlining the discovery process and enhancing overall efficiency, allowing you to focus on high-priority tasks.

Optimize Candidate Identification

We offer bespoke AI systems designed to match your unique workflows and challenges, optimizing drug candidate identification and enhancing testing accuracy for your organization.

Faster Time to Market

Our solutions drastically reduce the time it takes to bring new drugs to market, helping you stay competitive and meet the growing demand for innovative treatments.

Enhance Testing Accuracy

By integrating AI into the drug discovery process, we enhance testing accuracy and the precision of drug efficacy predictions, leading to more reliable and consistent outcomes.

Optimized Cost Efficiency

Our AI-powered solutions reduce R&D expenses by optimizing processes and minimizing costly trial-and-error, making drug development more cost-effective.

Competitive Advantage

With faster, more efficient, and more accurate drug discovery, our solution provides you with a competitive edge, enabling you to lead the race to develop the next breakthrough treatment.

500+

Successful AI-driven projects

11+

Year of expertise in delivering AI Solutions

40+

AI, ML, and data tools mastered

200+

Dedicated AI experts

OUR PROCESS

Accelerating Every Step of AI-Powered Drug Discovery in 3 Steps

We guide you through every phase, from customized Proof of Concept to post-implementation support, ensuring faster, more efficient drug discovery.

Step 1

Evaluate

Assess current workflows, identify pain points, and define AI objectives.

Conduct gap analysis for data readiness and system compatibility.

Evaluate potential risks, benefits, and compliance with industry regulations.

Define key metrics for success and AI integration outcomes.

Step 2

Explore

Prepare high-quality, standardized data, ensuring accuracy and consistency.

Utilize real-world datasets to create unbiased, representative AI models.

Identify impactful AI use cases aligning with drug discovery objectives.

Ensure ethical AI practices, focusing on transparency and fairness.

Step 3

Execute

Develop and implement AI solution, optimizing discovery from molecule identification.

Integrate AI tools seamlessly with systems for improved workflow efficiency.

Deliver Proof of Concept (POC) to demonstrate AI effectiveness.

Monitor and optimize AI performance, ensuring long-term compliance.

TESTIMONIAL SECTION

What Our Clients Say About Us

50 %

Faster modernization cycle

30 - 40 %

Lower engineering costs

80 %

Fewer bugs and reworks

50 %

Faster launch timelines

Intellivon’s AI solution revolutionized our drug discovery process. By automating key stages, we were able to reduce our research timelines by 40%, enabling us to bring new treatments to market faster. Their tailored approach truly made a difference for our team.
Sarah L., Director of R&D, Global Pharmaceutical Company
Working with Intellivon has been a game-changer. Their AI-driven platform helped us optimize our drug candidate screening with remarkable accuracy, cutting down our testing costs by 25%. Their team’s ongoing support ensured seamless integration with our systems.
David M., Chief Scientific Officer, Biotech Startup
Thanks to Intellivon’s AI solutions, we were able to identify promising drug candidates from a massive dataset quickly. The platform’s ability to predict ADMET properties early on saved us months of work and minimized risk. We couldn’t be more satisfied with the results.
Emily W., VP of Drug Discovery, Leading Biopharma
Intellivon’s tailored AI technology accelerated our drug discovery pipeline, improving both speed and precision. Their team guided us through every step, from the proof of concept to full integration, making the whole process smooth and effective.
James R., Head of Research Operations, Pharma Innovator
We chose Intellivon because of their commitment to creating a solution that meets our unique needs. Their AI platform didn’t just speed up our discovery process; it also improved the accuracy of our predictions, allowing us to make more informed decisions earlier in the process.
Laura T., Chief Technology Officer, Pharmaceutical Research Firm
BLOGS
AI & Healthcare Insights from
Intellivon

Our exclusive platform where we share expert perspectives and guidance for your AI journey.

CONTACT US
Connect with Our Healthcare AI Experts Today